Faivre-Finn, C.Vicente, D.Kurata, T.Planchard, D.Paz-Ares, L.Vansteenkiste, J. F.Spigel, D. R.Garassino, M. C.Reck, M.Senan, S.Naidoo, J.Rimner, A.Wu, Y-L.Gray, J. E.Ozguroglu, M.Lee, K. H.Newton, M.Wang, L.Thiyagarajah, P.Antonia, S. J.2025-01-072025-01-072020-09-010923-7534https://hdl.handle.net/10668/27553enDurvalumab after chemoradiotherapy in stage III NSCLC: 4-year survival update from the phase III PACIFIC trialconference outputopen access10.1016/j.annonc.2020.08.22811569-8041http://www.annalsofoncology.org/article/S0923753420423634/pdf573469102679